Shire buys US drugs rival for $32bn

lundi 11 janvier 2016

UK pharmaceutical firm Shire reaches a $32bn (£22bn) deal for US rival Baxalta to create rare-disease drugs giant. Shire buys US drugs rival for $32bn

0 commentaires:

Enregistrer un commentaire